×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [itt population]
D_Piperaquine
23 views
PPT - US Food and Drug Administration Home Page
953 views
Workshop 4: Il late-presenter Moderatori: G. Ippolito, M. Moroni Discussant: R. Iardino Risposta virologico-clinica e scelta della terapia C. Mussini
217 views
ISSUES THAT PLAGUE NON- INFERIORITY TRIALS PAST AND FUTURE RALPH B. DAGOSTINO, SR. BOSTON UNIVERSITY HARVARD CLINICAL RESEARCH INSTITUTE
218 views
James Hung, 2004 FDA/Industry Management of Missing Data in Clinical Trials from a Regulatory Perspective H.M. James Hung Div. of Biometrics I, OB/OPaSS/CDER/FDA
217 views
CLINICAL & COST- EFFECTIVENESS OF NEURAMINIDASE INHIBITORS FOR THE TREATMENT & PREVENTION OF INFLUENZA Nicola Cooper, PhD & Alex Sutton, PhD Centre for
214 views
Slides
213 views
A turning point in adjuvant therapy: Optimizing use of aromatase inhibitors P Pronzato Genova
216 views
Intermediate stage HCC treatment options: TACE + sorafenib
228 views
RECIST Overview. Introduction What is RECIST? RECIST Endpoints in Berenice Definitions Methods of Assessment Schedule of Assessments Evaluation
225 views
Current Opinion in the Colorectal Cancer Treatment Dott. Carlo Garufi Oncologia Medica C Istituto Regina Elena – Roma
[email protected]
217 views
J. Tabernero E. Aranda, A. Gomez, B. Massutí, J. Sastre, A. Abad,
40 views
Next >